<table id="Table1" width="90%" xmlns="urn:hl7-org:v3" xmlns:voc="urn:hl7-org:v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption stylecode="Lrule Rrule Toprule">Table 1.   Select Mean (±S.D.) Metformin Pharmacokinetic Parameters Following Single or Multiple Oral Doses of Metformin Hydrochloride Tablets</caption>
<col align="left"></col>
<col align="center"></col>
<col align="center"></col>
<col align="center"></col>
<thead>
<tr>
<th align="center" stylecode="Lrule">Subject Groups: Metformin hydrochloride tablets dose (number of subjects)
                                                        <br/>
<sup>a</sup>
<br/>
</th>
<th stylecode="Lrule">C (µg/mL)
                                                        <br/>
<sub>max</sub>
<sup>b</sup>
<br/>
</th>
<th stylecode="Lrule">T (hrs)
                                                        <br/>
<sub>max</sub>
<sup>c</sup>
<br/>
</th>
<th stylecode="Lrule Rrule">Renal Clearance (mL/min)
                                                        <br/>
<br/>
</th>
</tr>
</thead>
<tfoot>
<tr>
<td colspan="4">
<paragraph> All doses given fasting except the first 18 doses of the multiple dose studies
                                                            <caption>
<sup>a</sup>
</caption>
</paragraph>
</td>
</tr>
<tr>
<td colspan="4">
<paragraph> Peak plasma concentration
                                                            <caption>
<sup>b</sup>
</caption>
</paragraph>
</td>
</tr>
<tr>
<td colspan="4">
<paragraph> Time to peak plasma concentration
                                                            <caption>
<sup>c</sup>
</caption>
</paragraph>
</td>
</tr>
<tr>
<td colspan="4">
<paragraph> Combined results (average means) of five studies: mean age 32 years (range 23-59 years)
                                                            <caption>
<sup>d</sup>
</caption>
</paragraph>
</td>
</tr>
<tr>
<td colspan="4">
<paragraph> Kinetic study done following dose 19, given fasting
                                                            <caption>
<sup>e</sup>
</caption>
</paragraph>
</td>
</tr>
<tr>
<td colspan="4">
<paragraph> Geriatric subjects, mean age 71 years (range 65-81 years)
                                                            <caption>
<sup>f</sup>
</caption>
</paragraph>
</td>
</tr>
<tr>
<td colspan="4">
<paragraph> CL = creatinine clearance normalized to body surface area of 1.73 m
                                                            <caption>
<sup>g</sup>
</caption>
<sub>cr</sub>
<sup>2</sup>
</paragraph>
</td>
</tr>
</tfoot>
<tbody>
<tr>
<td stylecode="Lrule Rrule">   500 mg single dose (24)    850 mg single dose (74)    850 mg three times daily for 19 doses (9)
                                                        <content stylecode="bold">Healthy, nondiabetic adults:</content>
<br/>
<br/>
<sup>d</sup>
<br/>
<sup>e</sup>
</td>
<td stylecode="Rrule">1.03 (±0.33) 1.60 (±0.38) 2.01 (±0.42)
                                                        <br/>
<br/>
<br/>
</td>
<td stylecode="Rrule">2.75 (±0.81) 2.64 (±0.82) 1.79 (±0.94)
                                                        <br/>
<br/>
<br/>
</td>
<td stylecode="Rrule">600 (±132) 552 (±139) 642 (±173)
                                                        <br/>
<br/>
<br/>
</td>
</tr>
<tr>
<td stylecode="Toprule Rrule Lrule">   850 mg single dose (23)    850 mg three times daily for 19 doses (9)
                                                        <content stylecode="bold">Adults with type 2 diabetes:</content>
<br/>
<br/>
<sup>e</sup>
</td>
<td stylecode="Toprule Rrule">1.48 (±0.5) 1.90 (±0.62)
                                                        <br/>
<br/>
</td>
<td stylecode="Toprule Rrule">3.32 (±1.08) 2.01 (±1.22)
                                                        <br/>
<br/>
</td>
<td stylecode="Toprule Rrule">491 (±138) 550 (±160)
                                                        <br/>
<br/>
</td>
</tr>
<tr>
<td stylecode="Toprule Rrule Lrule">   850 mg single dose (12)
                                                        <content stylecode="bold">Elderly , healthy nondiabetic adults:
                                                            <sup>f</sup>
</content>
<br/>
</td>
<td stylecode="Toprule Rrule">2.45 (±0.70)
                                                        <br/>
</td>
<td stylecode="Toprule Rrule">2.71 (±1.05)
                                                        <br/>
</td>
<td stylecode="Toprule Rrule">412 (±98)
                                                        <br/>
</td>
</tr>
<tr>
<td stylecode="Toprule Rrule Lrule">         (CL 61-90 mL/min) (5)      (CL 31-60 mL/min) (4)      (CL 10-30 mL/min) (6)
                                                        <content stylecode="bold">Renal-impaired adults:</content>
<br/>
<content stylecode="bold">850 mg single dose</content>
<br/>
<content stylecode="bold">Mild</content>
<sub>cr</sub>
<sup>g</sup>
<br/>
<content stylecode="bold">Moderate</content>
<sub>cr</sub>
<br/>
<content stylecode="bold">Severe</content>
<sub>cr</sub>
</td>
<td stylecode="Toprule Rrule">1.86 (±0.52) 4.12 (±1.83) 3.93 (±0.92)
                                                        <br/>
<br/>
<br/>
<br/>
</td>
<td stylecode="Toprule Rrule">3.20 (±0.45) 3.75 (±0.50) 4.01 (±1.10)
                                                        <br/>
<br/>
<br/>
<br/>
</td>
<td stylecode="Toprule Rrule">384 (±122) 108 (±57) 130 (±90)
                                                        <br/>
<br/>
<br/>
<br/>
</td>
</tr>
</tbody>
</table>